Activating Experienced Managers at Established Funds

THE WOMEN'S

HEALTH FUND

black curved line

Meet the market-building fund of funds in women’s health.

Don’t Predict. Create.

80% funds.

20% direct co-invest.

Funds

It is time to activate experienced managers at established funds for women’s health. Designed as a market building vehicle, we are partnering with fund managers that have billions under management to drive investment into areas that differently, disproportionately, or exclusively impact women.

Direct Co-Invest

Through our fund investments, we have visibility into a wide range of women’s health opportunities. Sourced from our portfolio funds, our direct investments are in late-stage therapeutics and commercial-stage medtech, tech-bio, digital health.

Partners

Fund Managers

With billions under management, these managers are known for their experience and their results. We are activating venture capital leaders into women’s health, and supporting the growth of the women’s health companies in their portfolios.

Strategics

The biopharma industry plans decades ahead to develop new therapies. They are experts at building the market, educating thought leaders and payers, evolving guidelines, and raising awareness. We are partnered with some of the top market builders to support commercial growth.

Foundations

Visionary foundations and philanthropists deliver generational impact through sustainable market development. These high-impact donors are partnering in novel ways to jump-start the market, while also providing non-dilutive top-ups and other infrastructure support to eligible women’s health companies.

Thought Leaders

Building a market requires stakeholders from across the ecosystem, including researchers, policy makers, educators, media, health care providers, tech giants, and data leaders. We are partnering strategically and deliberately to ensure system wide growth.

The Big Picture

  • We didn’t really include women in clinical trials till 1993 - and that was just NIH funded studies. And the FDA guidance on collecting data about women’s hormones and cycles during studies was only issued in January of 2025.

    Men have been the default for scientific research - male cells, male mice, and first-in-man studies. Even though women experience side effects from medicines at about twice the rate of men.

    Because we have excluded women and sex-specific considerations from research for so long, we have a significant data gap. meaning that it’s still early days for the field of women’s health. It was only in 2024 that we first saw what pregnancy does to a woman’s brain, and in 2025 that we first learned how an embryo implants. On a genetic level, laboratories are starting to make progress in understanding the role of women’s second X chromosome, the one formerly known as silent.

    As science progresses, investment is starting to follow. But not fast enough. In the last three years, the largest dedicated women’s health fund has gone from $40 million to over $250 million. But women’s health was still only $1.3B of the $33B in deals in 2024.

    It’s time to intentionally build the market for women’s health, activating experienced managers at established funds into this opportunity space.

  • Building a market means involving the entire ecosystem. We are working with some of the best placed individuals and organizations on the planet to accelerate progress. This includes investors, foundations, industry, market leaders, founders, researchers, and more.

  • This is a market building fund of funds designed to activate experienced managers at established funds. The portfolio will consist of 80% funds and 20% direct co-investments into women’s health companies sourced from portfolio funds. We are partnering with early to late stage funds active across therapeutics, diagnostics, devices, med-tech, and digital health.

  • Deliberately. We can build the market for women’s health. We can activate leading investors and unlock billions in capital. We can develop and launch new diagnostics, treatments and cures. And we will. Come join us.

  • We recommend the following resources:

Contact

Complete the form below to get in touch, or connect with us on LinkedIn.